A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting

Taylor and Francis Group, Expert Opinion on Drug Safety, 9(21), p. 1193-1204, 2022

Journal article published in 2022 by Raymond Li

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by